Sections or subsections omitted from the full prescribing information are not listed. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Osimertinib vs comparator egfrtki as firstline treatment for egfrm advanced. Reduce xalkori dosage in patients with moderate or severe hepatic impairment. Highlights of prescribing information cardiac dysfunction. For the treatment of patients with metastatic nonsmall cell. Highlights of prescribing information employ more intensive. Firstline crizotinib versus chemotherapy in alkpositive lung cancer. Crizotinib can cause serious heart or liver problems. Xalkori crizotinib fdaapproved patient labeling pfizer.
Xalkori is a prescription medicine used to treat people with nonsmall cell lung cancer nsclc that has spread to other parts of the body and is caused by a defect in either a gene called alk anaplastic. Find information on the resources available to patients prescribed a pfizer oncology medication. Please choose the category that best describes you. Zykadia is a prescription medicine that is used to treat people with nonsmall cell lung cancer nsclc that. Jakafi is indicated for treatment of intermediate or highrisk myelofibrosis mf, including primary mf, postpolycythemia vera mf and postessential thrombocythemia mf in adults. Gleevec imatinib mesylate tablets, for oral use initial u. On cycle 1 day 22, start venclexta according to the 5week rampup schedule see table 1.
Increased transaminases generally occurred within the first 2. Druginduced hepatotoxicity with fatal outcome occurred in 0. Highlights of prescribing information patients at risk. Mar 17, 2020 crizotinib can cause serious heart or liver problems. The log of the distribution coefficient octanolwater at ph 7. The usual dose of crizotinib is 250 mg orally twice a day. Follow the directions on your prescription label carefully. Highlights of prescribing information these highlights do not include all the information needed to use tagrisso. The solubility of crizotinib in aqueous media decreases over the range of ph 1. Aug 07, 2019 usual adult dose for nonsmall cell lung cancer.
May 19, 2017 notably, 73% of crizotinib patients who had progressive disease continued crizotinib therapy for a median of 3. Name vysis alk break apart fish probe kit intended use. The specific antibody can be visualized using optiview dab ihc detection. Highlights of prescribing information perforation can occur.
Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in this package insert. Clinical use of crizotinib for the treatment of nonsmall. Alectinib versus crizotinib in untreated alkpositive nonsmallcell lung cancer. See full prescribing information for complete boxed warning. Firstline crizotinib versus chemotherapy in alkpositive. The solubility of crizotinib in aqueous media decreases over the range ph 1. Is caused by a defect in a gene called anaplastic lymphoma kinase alk and has spread to other.
This medicinal product should not be used during pregnancy unless the clinical condition of the mother requires treatment. Refer to the dabrafenib prescribing information for recommended dabrafenib dosing information. Infusion reactions and cardiopulmonary arrest 1 indications and usage 1. Summary of product characteristics and package leaflet. Package insert instructions must be followed accordingly. Serious infections leading to hospitalization or death, including tuberculosis and bacterial, invasive fungal, viral, and other opportunistic infections. Xalkori is a kinase inhibitor indicated for the treatment of patients with metastatic nonsmall cell lung cancer nsclc whose tumors are anaplastic lymphoma kinase alk or ros1positive as detected by. Read full important safety information and approved use. The use of singleagent crizotinib in the treatment of locally advanced or metastatic alkpositive nsclc was investigated in two multicenter, singlearm studies studies a and b.
Ventana alk d5f3 cdx assay is a rabbit monoclonal primary antibody that binds to alk in paraffinembedded tissue sections. Highlights of prescribing information these highlights do not include all the information needed to use gleevec safely and effectively. Draft guidance on crizotinib recommended jul 2014 this draft guidance, once finalized, will represent the food and drug administrations fdas current thinking on this topic. Ventana alk d5f3 cdx assay and detection with amplification vs.
Alectinib versus crizotinib in untreated alkpositive nonsmall cell lung cancer. Highlights of prescribing information these highlights do not include all the information needed to use alecensa safely and effectively. About xalkori crizotinib xalkori is a kinase inhibitor indicated in the u. Serious infections leading to hospitalization or death, including tuberculosis and bacterial, invasive fungal, viral, and other opportunistic infections, have occurred.
This package insert must be read carefully prior to use. Crizotinib for the treatment of nonsmallcell lung cancer. Caprelsa vandetanib tablets for oral use initial u. Lung cancer is the leading cause of cancer mortality in the us and worldwide.
Alecensa alectinib capsules, for oral use initial u. Xalkori is a prescription medicine used to treat people with nonsmall cell lung cancer nsclc that has spread to other parts of the body and is caused by a defect in either a gene called alk anaplastic lymphoma kinase or a gene called ros1. Information for the user xalkori 200 mg hard capsules xalkori 250 mg hard capsules crizotinib read all of this leaflet carefully before you start taking this medicine because it contains. Tagrisso osimertinib tablets, for oral use initial u. Crizotinib is available as both 200mg and 250mg capsules. Highlights of prescribing information visual disturbance. Xalkori is a kinase inhibitor indicated for the treatment of patients with metastatic nonsmall cell lung cancer nsclc whose tumors are anaplastic lymphoma kinase alk or ros1positive as detected by an fdaapproved test 1, 2. Crizotinib is an oral selective small molecule tyrosine kinase inhibitor. Restricted access do not disseminate or copy without approval. Draft guidance on crizotinib food and drug administration. For the treatment of patients with metastatic nonsmall cell lung cancer nsclc whose tumors are anaplastic lymphoma kinase alk or ros1positive as detected by an fdaapproved test. Coadministration of a single 150 mg oral dose of crizotinib in the presence of. Druginduced hepatotoxicity including cases with fatal outcome has been reported in patients treated with crizotinib across clinical trials see section 4. Druginduced hepatotoxicity with fatal outcome has occurred.
Crizotinib is primarily metabolized via odealkylation, with subsequent phase 2 conjugation of metabolites through cytochrome p450 cyp isoenzyme 3a45. Please see full prescribing information for xalkori. However, across clinical trials no renal abscesses were confirmed by microbiology tests. Pregnant women, or patients becoming pregnant while receiving crizotinib. Apr 26, 20 clinical development of crizotinib for nsclc. Food and drug administration granted accelerated approval to brigatinib alunbrig tablets, takeda. Xalkori crizotinib highlights pfizer medical information us.
If a serious infection develops, interrupt xeljanzxeljanz xr until the infection is controlled. In order to provide you with relevant and meaningful content we need to know more about you. On cycle 1 day 22, start venclexta according to the 5week ramp. Refer to the obinutuzumab prescribing information for recommended obinutuzumab dosing information. After completing the rampup schedule on cycle 2 day 28, patients should continue. It is usually taken with or without food twice a day. Dosing information for xalkori crizotinib, an rx treatment option for alkpositive or ros1positive metastatic nsclc. Pregnant women, or patients becoming pregnant while receiving crizotinib, or treated male patients as partners of a pregnant women, should be apprised of the potential hazard to the fetus.
Crizotinib is a white to paleyellow powder with a pka of 9. Tarceva is not recommended for use in combination with platinumbased chemotherapy see clinical studies 14. It is not known if zykadia is safe and effective in children. Xalkori crizotinib prior auth criteria proprietary information. For patients treated with a lower dose of crizotinib than 250 mg twice daily, then follow the. Take crizotinib at around the same times every day.
These highlights do not include all the information needed to use imbruvica safely and effectively. Xalkori crizotinib highlights pfizer medical information. Crizotinib concentrations increased in patients with preexisting moderate any ast and total bilirubin 1. These highlights do not include all the information needed to use. Refer to an fdaapproved tests package insert for instructions on the identification of patients eligible for. It is not known if xalkori is safe and effective in children. Is caused by a defect in a gene called anaplastic lymphoma kinase alk and has spread to other parts of the body. Crizotinib versus chemotherapy in advanced alkpositive lung cancer. This is the dose studied in the crizotinib clinical trials and the maximum dose listed in the. Monitor liver function tests including alt, ast, and total bilirubin every 2 weeks during the first 3 months of treatment, then once a month and as clinically indicated, with more frequent testing in patients who develop transaminase and bilirubin elevations. Information for the user xalkori 200 mg hard capsules xalkori 250 mg hard capsules crizotinib read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
321 171 485 233 857 128 747 906 713 510 17 737 342 470 1416 674 1157 1207 474 685 1455 471 1468 1162 1199 800 909 411 875 439 97